Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

99.41 -0.67 (-0.67%)

Streaming Delayed Price Updated: 2:29 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

71 72 Next >

Comparative Study: BioNTech And Industry Competitors In Biotechnology Industry ↗

October 05, 2023

Via Benzinga

Why Novavax Stock Fell Today ↗

October 04, 2023

Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated...

Via Benzinga

Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares ↗

October 04, 2023

3D Medicines Inc. was trading 7.2% higher in the Hong Kong Wednesday morning session at HK$5.53 after the company announced that it is buying back up to 10% of its own stock.

Via Benzinga

Short Sellers Are Betting Against Novavax (NVAX) Stock ↗

October 04, 2023

Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap.

Via InvestorPlace

Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna ↗

October 03, 2023

The company can now join Pfizer and Moderna in launching an updated booster in the U.S.

Via Investor's Business Daily

Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On? ↗

October 03, 2023

Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S.

Via Benzinga

Nobel Prize Honors Scientists Behind mRNA Vaccines Against Covid-19 ↗

October 02, 2023

Discover the remarkable journey of Nobel Prize laureates Kariko and Weissman, who transformed medicine with mRNA vaccines, and the financial impact on Moderna and Pfizer stocks.

Via Benzinga

3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street ↗

October 01, 2023

Analysts like these stocks for very good reasons.

Via The Motley Fool

Why Pfizer and BioNTech Stocks Zoomed Higher Today ↗

September 29, 2023

The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle.

Via The Motley Fool

Why CureVac Stock Plunged Today ↗

September 29, 2023

A German court temporarily suspended proceedings in CureVac's IP lawsuit against BioNTech.

Via The Motley Fool

Topics Lawsuit

Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine

September 28, 2023

From BioNTech SE

Via GlobeNewswire

Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs ↗

September 27, 2023

U.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria. More than a million people worldwide succumb to infections caused...

Via Benzinga

DNA Stock Alert: Ginkgo Bioworks Announces Major Partnership With Pfizer ↗

September 27, 2023

The deal keeps Ginkgo alive, but its business model of becoming the "Apple Store of Biotech" remains unproven. DNA stock jumped overnight.

Via InvestorPlace

Updated Covid Vaccine US Rollout Hit by Insurance Coverage Delays - What It Means? ↗

September 20, 2023

As the U.S.

Via Benzinga

With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock? ↗

September 20, 2023

All three companies should benefit from increased COVID-19 booster sales.

Via The Motley Fool

Pancreatic Cancer Battle Boosted by $200M VC Firm

September 19, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:MACK),(NASDAQ:INCY),(NASDAQ:MRTX),(NASDAQ:BNTX) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Death

10 Health Care Stocks Whale Activity In Today's Session ↗

September 18, 2023

Via Benzinga

BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission

September 18, 2023

From BioNTech SE

Via GlobeNewswire

More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone ↗

September 15, 2023

New COVID-19 boosters have been approved by the U.S. FDA in the fight against new variants. A new survey showed how likely people are to get new boosters and if they will have their children get...

Via Benzinga

The 3 Most Undervalued Pharma Stocks to Buy in September 2023 ↗

September 14, 2023

Investing in pharmaceutical industry always carries risk, but several pharma stocks have an attractive risk/reward valuation right now.

Via InvestorPlace

Moderna Stock Has Been Beaten Up; Why The CFO Says Its Story Is 'Misunderstood' ↗

September 13, 2023

Moderna unveiled promising results in flu on Wednesday, adding to its respiratory suite.

Via Investor's Business Daily

DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories ↗

September 12, 2023

Benzinga

Via Benzinga

Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits ↗

September 11, 2023

The U.S.

Via Benzinga

Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine

September 11, 2023

From Pfizer Inc.

Via Business Wire

Non-Disappearing COVID Creates Another Chapter For The Pharmaceutical Industry ↗

September 06, 2023

On Tuesday, UK regulators joined their US and European peers in approving an updated COVID-19 vaccine by Pfizer Inc (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) that targets only the...

Via Benzinga

Here's How Moderna's Updated Covid Shot Stacks Up Against Highly Mutated 'Pirola' Variant ↗

September 06, 2023

Pirola has about 30 mutations compared with previous omicron versions of the virus.

Via Investor's Business Daily

3 Stocks to Buy For the COVID Resurgence

September 06, 2023

The cold and flu season is upon us, but COVID-19 cases and hospitalizations have also increased recently. The Centers for Disease Control (CDC) will be voting

Via MarketBeat

Cancer Remains Pharma's Biggest Challenge And Mainz Biomed Has The Tool To Help Win The Battle ↗

September 05, 2023

Last week, The European Commission authorizing Comirnaty, a third version of the updated COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) to be used in EU countries'...

Via Benzinga

Week In Review: GenFleet Out-Licenses Three Candidates To Verastem In $625 Million Deal ↗

September 02, 2023

Shanghai GenFleet Technologies partnered three preclinical small-molecule candidates for RAS pathway-driven cancers to Verastem Oncology in a deal that could be worth up to $625.5 million. GenFleet...

Via Talk Markets

Jeff Bezos Vs. Elon Musk Space Contract Lawsuit, Novo Nordisk's Famed Drug Ozempic Could Be Next Contender For Medicare Negotiations, Tesla Rival XPeng's August Deliveries Zooms 43%: Today's Top Stories ↗

September 01, 2023

Tech Crunch

Via Benzinga

Topics Lawsuit

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

71 72 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.